On April 2, 2014, the Competition Bureau released a draft update for public consultation of its Intellectual Property Enforcement Guidelines (“IPEGs”).
April 09, 2014
This was an application for judicial review of a decision of the Minister of Health (“Minister”) which denied the listing of Eli Lilly Canada Inc.’s patent.
April 08, 2014
The CPSO recently approved a draft policy entitled, “Physicians’ Relationship with Industry: Practice, Education and Research”, for consultation.
April 03, 2014
Over the past year, there were a number of notable developments relating to branding and naming of pharmaceutical products in Canada.
March 26, 2014
In 2010, the provinces and territories announced the creation the Pan-Canadian Pricing Alliance (“PCPA”). The PCPA is an initiative aimed at joint negotiations on..
March 25, 2014
On March 14, 2014, the Court of Appeal released two decisions with respect to proceedings commenced pursuant to section 8 of the Patented Medicines Regulations.
March 24, 2014
Over the past year, there were a number of notable developments in matters relating to branding and naming of pharmaceutical products in Canada.
March 17, 2014
This case concerns a proposed generic version of the brand name drug PATADAY, an eye drop solution used to treat allergic and inflammatory eye reactions.
Many of the provisions of Canada’s law governing commercial electronic messages (CEMs) will come into effect on July 1, 2014.
February 19, 2014
There have been a number of developments in biosimilars of late, including regulatory approvals in Canada issued on January 15, 2014 for two biosimilar products,...
January 23, 2014
Try searching our global site instead